Inverness Continues 2007 Buying Spree, Adds Matritech Assets For $36 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Inverness Medical continues to build its worldwide distribution capabilities with the $36 million purchase of Matritech's assets, the firm's tenth acquisition or joint venture announced this year
You may also be interested in...
Inverness Acquisition Surge Aims To Grow Annual Sales To $3 Billion By 2012
Inverness Medical Innovations plans to continue its recent acquisition spree with the goal of achieving $3 billion in annual revenues by the end of 2012, the company says
Inverness Acquisition Surge Aims To Grow Annual Sales To $3 Billion By 2012
Inverness Medical Innovations plans to continue its recent acquisition spree with the goal of achieving $3 billion in annual revenues by the end of 2012, the company says
Inverness acquires Alere
Inverness Medical Innovations continues its acquisition spree with the $302 million purchase of Alere, a provider of health and care-management services for patients with heart failure and other chronic illnesses, in agreement announced Oct. 24. The purchase complements Inverness's cardiac management and diagnostic technologies, and is consistent with the firm's overall acquisition strategy, according to CEO Ron Zwanziger (1"The Gray Sheet" Sept. 3, 2007, p. 9). The transaction, which includes $125 million in cash and $177 million in Inverness common stock, is expected to close at the end of 2007. Alere is expected to have 2007 revenues of $77 million